Praxis Precision Medicines, Inc. · NASDAQ:PRAX

Sniecinski Megan received 21 Praxis Precision Medicines, Inc. shares as an award (Form 4)

Traded Nov 13, 2026 · Filed Nov 18, 2026

On Nov 13, 2026, Sniecinski Megan (Chief Operating Officer) received 21 Praxis Precision Medicines, Inc. shares as an award at US$278.91 for US$5,857, leaving 28,685 shares. Filed Nov 18, 2026 (Form 4).

Awarded
21 shares
Price
US$278.91
Value
US$5,857
Holding after
28,685 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 13, 2026Common StockAward21US$278.9128,685Direct

Source

Download original · View original at SEC

Related